pembrolizumab
merck
['kn-407', 'lcsm,(-blcsm)']
 5-years os update kn-407 5yos: 18.4% vs 9.7% 5ypfs: 10.8% vs 3.5% #esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm